Jazz Pharmaceuticals has appointed Jeffrey Tobias as their new Senior Vice President of Research and Development and also as Chief Medical Officer.
Dr Tobias brings twenty years of experience in the biopharmaceutical industry and has also served for a decade in clinical and academic medicine.
Bruce Cozadd, Chairman and Chief Executive Officer of Jazz Pharmaceuticals, says that Dr Tobias has a “unique combination” of drug development skills and broad medical knowledge.
“His breadth of experience, business acumen, strong intellect and focus on patients will serve us well as we build a targeted pipeline of important new medical treatments that will complement our growing commercial products,” added Bruce Cozadd.
The new R&D head will start his position from October 17.
Jazz Pharmaceuticals recently merged with Ireland-based Azur Pharma Limited.